The Institutional Biosafety Committee (IBC) is an appropriately constituted administrative body established to oversee the biohazardous or recombinant agents used for research and educational purposes by Texas A&M International University (TAMIU) faculty, employees, graduate, and undergraduate students, regardless of the source of funding. IBC supervises biohazardous or recombinant agent research in accordance with the National Institutes of Health (NIH) Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines).


     I.  Guide to the IBC Application Process - Researchers Start Here

    II.  IBC Forms, Guidelines/Regulations and Useful Links

   III.  Training - Required

   IV.  IBC Members

    V.  Frequently Asked Questions

   VI.  TAMIU IBC Policy and Procedures Manual (available from IBC Chair)


If you have questions, please contact the IBC Chair
Dr. Michael Kidd, (michael.kidd@tamiu.edu, LBV312B, 956-326-2585)



Return to Research Compliance Homepage